




Mounjaro 2.5mg KwikPen Solution For Injection 2.4ml Pre-Filled Pens (Eli Lilly and Company Ltd) (FREE NEEDLES SUPPLIED)


*** Your prescriber MUST be CQC registered for this product to be prescribed, please ask them to include their CQC location ID and postcode on the prescriptions notes. Any orders from prescribers without CQC registration will be rejected (Does not apply to Pharmacist prescribers) *** FOR PRESCRIBERS PLEASE INPUT THE BMI OF THE PATIENT SOMEWHERE ON THE PRESCRIPTION, WITHOUT THIS THE ORDER WILL BE DELAYED AS WE WILL HAVE TO CONTACT YOU FOR THIS INFORMATION Mounjaro (tirzepatide) 2.5 mg injection, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age. It is a single molecule designed to bind to glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. Mounjaro represents a different class of medicines introduced for adults with type 2 diabetes. It works differently by directly activating GIP and GLP-1 pathways to help regulate blood sugar.
Compare insurance quotes from trusted partners.
5.0 (4,014)
238 products
6,779 sold
Results from Mounjaro 2.5mg KwikPen can typically be observed within a few weeks of starting treatment, with optimal results often seen after several months of consistent use. Individual responses may vary based on factors such as diet and lifestyle. It's essential to follow your healthcare professional's guidance for the best outcomes in managing weight and improving overall health.
The results of Mounjaro 2.5mg KwikPen can vary among individuals, but patients typically experience significant weight loss and improved metabolic health within a few months of treatment. Maintenance of these results largely depends on continued adherence to a balanced diet and exercise regimen. Regular consultations with your healthcare provider are essential for optimal outcomes.
Mounjaro 2.5mg KwikPen Solution for Injection is not suitable for everyone. It is primarily prescribed for individuals with type 2 diabetes and may not be appropriate for those with certain medical conditions or allergies. A healthcare professional should evaluate your health history to determine if Mounjaro is right for you, ensuring safe and effective use of this pre-filled pen solution.
Common side effects of Mounjaro 2.5mg KwikPen may include nausea, vomiting, diarrhoea, and decreased appetite. Some users may also experience fatigue or headaches. Serious side effects can occur but are rare; consult your healthcare provider for personalised advice. Always discuss potential risks and benefits before starting treatment with this injectable solution to ensure it meets your aesthetic goals safely.
Combining Mounjaro 2.5mg KwikPen Solution for Injection with other treatments should only be done under medical supervision. It’s essential to consult your healthcare provider to ensure safe and effective use alongside any additional therapies. They can guide you on possible interactions and tailor a treatment plan that suits your individual health needs and goals, optimising the benefits of Mounjaro.
After using Mounjaro 2.5mg KwikPen, it’s essential to follow proper aftercare. Inject at room temperature into the thigh, abdomen, or upper arm, ensuring rotation of injection sites to minimise irritation. Monitor for side effects such as nausea or injection site reactions. Store unused pens in the refrigerator and protect from light. Always consult your healthcare provider for personalised advice and report any concerning symptoms promptly.
7 day returns accepted for unopened items, no opened items will be refunded.
Buyer to cover cost for return and/or replacement item.
Incorrect goods must be returned for replacement at a cost to seller.
Dpd courier delays are not the responsibility of Aesthipharma. No refunds offered.
See company policy
© 2026 Faces Consent. All rights reserved.